The FDA issued 25 new and nine updated draft guidance documents intended to support development of generic medications including HIV antiretrovirals, antibiotics, ophthalmic drugs, cancer drugs, azelaic acid and ivermectin. The documents offer product-specific recommendations on the design of bioequivalence studies.
FDA issues 34 new or updated guidance docs on generics
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.